VivoSim Labs, Inc. (VIVS) Revenue History
Annual and quarterly revenue from 2014 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
VIVS Revenue Growth
VIVS Revenue Analysis (2014–2025)
As of May 8, 2026, VivoSim Labs, Inc. (VIVS) generated trailing twelve-month (TTM) revenue of $142,000, reflecting solid growth of +8.3% year-over-year. The most recent quarter (Q3 2026) recorded $26,000 in revenue, down 7.1% sequentially.
Looking at the longer-term picture, VIVS's 5-year compound annual growth rate (CAGR) stands at -42.0%, indicating revenue contraction over this period. The company achieved its highest annual revenue of $4.6 million in 2018.
When compared to Healthcare sector peers including IMNM (-23.2% YoY), KYMR (-12.6% YoY), and RXRX (+11.0% YoY), VIVS has underperformed the peer group in terms of revenue growth. Compare VIVS vs IMNM →
VIVS Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| $142,000 | +8.3% | -42.0% | -8761.1% | ||
| $7M | -23.2% | - | -3228.8% | ||
| $39M | -12.6% | +2.9% | -891.3% | ||
| $75M | +11.0% | +85.4% | -867.9% | ||
| $256M | +10.6% | +18.8% | -65.2% |
VIVS Historical Revenue Data (2014–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $144K | +32.1% | $139K | 96.5% | $-12,616,000 | -8761.1% |
| 2024 | $109K | -70.5% | $109K | 100.0% | $-15,086,000 | -13840.4% |
| 2023 | $370K | -75.3% | $370K | 100.0% | $-17,731,000 | -4792.2% |
| 2022 | $1.5M | - | $1.5M | 100.0% | $-11,479,000 | -765.3% |
| 2021 | $0 | -100.0% | $0 | - | $-16,826,000 | - |
| 2020 | $2.2M | -29.0% | $1.9M | 85.1% | $-21,475,000 | -977.9% |
| 2019 | $3.1M | -32.8% | $2.6M | 84.4% | $-27,274,000 | -882.4% |
| 2018 | $4.6M | +8.8% | $3.6M | 77.6% | $-35,271,000 | -766.3% |
| 2017 | $4.2M | +185.2% | $3.3M | 77.4% | $-38,575,000 | -911.9% |
| 2016 | $1.5M | +159.7% | $1.5M | 100.0% | $-38,643,000 | -2605.7% |
See VIVS's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs VIVS Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare VIVS vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonVIVS — Frequently Asked Questions
Quick answers to the most common questions about buying VIVS stock.
Is VIVS's revenue growth accelerating or slowing?
VIVS maintains +8.3% revenue growth, in line with its 5-year CAGR of -42.0%. TTM revenue stands at $142000.00. Growth rate remains consistent with historical average.
What is VIVS's long-term revenue growth rate?
VivoSim Labs, Inc.'s 5-year revenue CAGR of -42.0% reflects the sustained expansion pattern. Current YoY growth of +8.3% is near this long-term average.
How is VIVS's revenue distributed by segment?
VIVS reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2014-2025 are available for download. Segment mix reveals concentration and diversification trends.